Yang X - Search Results

1

Radiographic Features of Metastatic Brain Tumors from ALK-rearranged Non-small Cell Lung Cancer: Implications for Optimal Treatment Modalities.

Chu L, Ni J, Yang X, Tong T, Wang J, Yin F, Li R, Li Y, Zou L, Li Y, Xie C, Li G, Zhu Z. Chu L, et al. Among authors: yang x. J Cancer. 2019 Oct 22;10(26):6660-6665. doi: 10.7150/jca.30091. eCollection 2019. J Cancer. 2019. PMID: 31777594 Free PMC article.

2

Patterns and risks of postoperative recurrence in completely resected EGFR-mutant non-small cell lung cancer: prognostic significance of routine immunohistochemical markers.

Ni J, Guo T, Li Y, Yang X, Li Y, Zou L, Chu L, Chu X, Li S, Ye L, Zhang Y, Zhu Z. Ni J, et al. Among authors: yang x. Transl Lung Cancer Res. 2019 Dec;8(6):967-978. doi: 10.21037/tlcr.2019.12.02. Transl Lung Cancer Res. 2019. PMID: 32010575 Free PMC article.

3

Is clinical target volume necessary?-a failure pattern analysis in patients with locally advanced non-small cell lung cancer treated with concurrent chemoradiotherapy using intensity-modulated radiotherapy technique.

Zou L, Chu L, Xia F, Zhou L, Yang X, Ni J, Chen J, Zhu Z. Zou L, et al. Among authors: yang x. Transl Lung Cancer Res. 2020 Oct;9(5):1986-1995. doi: 10.21037/tlcr-20-523. Transl Lung Cancer Res. 2020. PMID: 33209618 Free PMC article.

4

A narrative review of evolving roles of radiotherapy in advanced non-small cell lung cancer: from palliative care to active player.

Zhou Y, Yu F, Zhao Y, Zeng Y, Yang X, Chu L, Chu X, Li Y, Zou L, Guo T, Zhu Z, Ni J. Zhou Y, et al. Among authors: yang x. Transl Lung Cancer Res. 2020 Dec;9(6):2479-2493. doi: 10.21037/tlcr-20-1145. Transl Lung Cancer Res. 2020. PMID: 33489808 Free PMC article. Review.

5

A brief report on incidence, radiographic feature and prognostic significance of brain MRI changes after anti-PD-1/PD-L1 therapy in advanced non-small cell lung cancer.

Ni J, Zhou Y, Wang S, Guo T, Hu J, Chu Q, Yang X, Chu L, Chu X, Li Y, Zhu Z. Ni J, et al. Among authors: yang x. Cancer Immunol Immunother. 2022 May;71(5):1275-1280. doi: 10.1007/s00262-021-03070-8. Epub 2021 Oct 6. Cancer Immunol Immunother. 2022. PMID: 34613418 Free PMC article.

6

Overall survival benefit of osimertinib and clinical value of upfront cranial local therapy in untreated EGFR-mutant nonsmall cell lung cancer with brain metastasis.

Zhao Y, Li S, Yang X, Chu L, Wang S, Tong T, Chu X, Yu F, Zeng Y, Guo T, Zhou Y, Zou L, Li Y, Ni J, Zhu Z. Zhao Y, et al. Among authors: yang x. Int J Cancer. 2022 Apr 15;150(8):1318-1328. doi: 10.1002/ijc.33904. Epub 2022 Jan 6. Int J Cancer. 2022. PMID: 34914096

7

Clinical outcomes of advanced non-small cell lung cancer patients harboring distinct subtypes of EGFR mutations and receiving first-line tyrosine kinase inhibitors: brain metastasis and de novo T790M matters.

Zeng Y, Guo T, Zhou Y, Zhao Y, Chu L, Chu X, Yang X, Ni J, Zhu Z. Zeng Y, et al. Among authors: yang x. BMC Cancer. 2022 Feb 21;22(1):198. doi: 10.1186/s12885-022-09245-5. BMC Cancer. 2022. PMID: 35189835 Free PMC article.

8

Neuroendocrine transformation from EGFR/ALK-wild type or TKI-naïve non-small cell lung cancer: An under-recognized phenomenon.

Chu X, Xu Y, Li Y, Zhou Y, Chu L, Yang X, Ni J, Li Y, Guo T, Zheng Z, Zheng Q, Yao Q, Li Y, Zhou X, Zhu Z. Chu X, et al. Among authors: yang x. Lung Cancer. 2022 Jul;169:22-30. doi: 10.1016/j.lungcan.2022.05.002. Epub 2022 May 17. Lung Cancer. 2022. PMID: 35609408 Free article.

9

Survival outcomes and symptomatic central nervous system (CNS) metastasis in EGFR-mutant advanced non-small cell lung cancer without baseline CNS metastasis: Osimertinib vs. first-generation EGFR tyrosine kinase inhibitors.

Zhou Y, Wang B, Qu J, Yu F, Zhao Y, Li S, Zeng Y, Yang X, Chu L, Chu X, Li Y, Zou L, Guo T, Ye L, Liang F, Wang S, Liu Q, Ni J, Zhu Z. Zhou Y, et al. Among authors: yang x. Lung Cancer. 2020 Dec;150:178-185. doi: 10.1016/j.lungcan.2020.10.018. Epub 2020 Nov 5. Lung Cancer. 2020. PMID: 33186860

10

Patterns of brain metastasis immediately before prophylactic cranial irradiation (PCI): implications for PCI optimization in limited-stage small cell lung cancer.

Chu X, Li S, Xia B, Chu L, Yang X, Ni J, Zou L, Li Y, Xie C, Lin J, Zhu Z. Chu X, et al. Among authors: yang x. Radiat Oncol. 2019 Sep 18;14(1):171. doi: 10.1186/s13014-019-1371-4. Radiat Oncol. 2019. PMID: 31533763 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

75,110 results

Search Page

Filters